Nisa Investment Advisors LLC increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 4.9% in the second quarter, Holdings Channel.com reports. The firm owned 33,421 shares of the company’s stock after acquiring an additional 1,555 shares during the period. Nisa Investment Advisors LLC’s holdings in Henry Schein were worth $2,441,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in HSIC. GAMMA Investing LLC boosted its stake in shares of Henry Schein by 37.8% in the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after purchasing an additional 1,081 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Henry Schein in the 1st quarter valued at $3,293,000. Palisade Capital Management LP boosted its stake in shares of Henry Schein by 16.7% in the 1st quarter. Palisade Capital Management LP now owns 44,163 shares of the company’s stock valued at $3,025,000 after purchasing an additional 6,304 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in shares of Henry Schein by 22.5% in the 1st quarter. OneDigital Investment Advisors LLC now owns 4,917 shares of the company’s stock valued at $337,000 after purchasing an additional 903 shares in the last quarter. Finally, IFM Investors Pty Ltd boosted its stake in shares of Henry Schein by 6.6% in the 1st quarter. IFM Investors Pty Ltd now owns 23,831 shares of the company’s stock valued at $1,737,000 after purchasing an additional 1,482 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.
Analysts Set New Price Targets
HSIC has been the subject of a number of research reports. Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a research report on Wednesday, October 8th. Stifel Nicolaus restated a “hold” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Finally, UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Five investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Henry Schein currently has an average rating of “Hold” and a consensus price target of $76.67.
Henry Schein Trading Up 0.9%
NASDAQ:HSIC opened at $62.90 on Friday. The company has a 50-day moving average price of $66.32 and a 200-day moving average price of $68.51. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The stock has a market cap of $7.63 billion, a price-to-earnings ratio of 20.29, a P/E/G ratio of 2.06 and a beta of 0.81.
Henry Schein (NASDAQ:HSIC – Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same period in the prior year, the business posted $1.23 earnings per share. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- What is the Euro STOXX 50 Index?
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- Airline Stocks – Top Airline Stocks to Buy Now
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Stock Dividend Cuts Happen Are You Ready?
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
